APO Research
Talk to an analyst

APO RESEARCH · REPORT

Next Generation AntiVirus

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Next Generation AntiVirus Market Analysis and Forecast 2026-2032

6 January 2026194 pages

Choose your research edition.

Industry ResearchNext Generation AntiVirus Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Next Generation AntiVirus Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Next Generation AntiVirus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next Generation AntiVirus Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Next Generation AntiVirus Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Next Generation AntiVirus market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Next Generation AntiVirus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Next Generation AntiVirus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Next Generation AntiVirus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Next Generation AntiVirus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Next Generation AntiVirus include Microsoft, CrowdStrike, Trend Micro, Trellix, Palo Alto Networks, Broadcom, Sophos, Bitdefender and Cisco, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Next Generation AntiVirus, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Next Generation AntiVirus, also provides the revenue of main regions and countries. Of the upcoming market potential for Next Generation AntiVirus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next Generation AntiVirus revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Next Generation AntiVirus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Next Generation AntiVirus revenue, projected growth trends, production technology, application and end-user industry.

Next Generation AntiVirus Segment by Company

Microsoft

CrowdStrike

Trend Micro

Trellix

Palo Alto Networks

Broadcom

Sophos

Bitdefender

Cisco

VMware Carbon Black

Check Point

Malwarebytes

Fortinet

BlackBerry Cylance

Next Generation AntiVirus Segment by Type

Behavior and Event-Driven

AI-Driven

Others

Next Generation AntiVirus Segment by Application

Finance and Insurance

Manufacturing

Internet and High Technology

Others

Next Generation AntiVirus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation AntiVirus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next Generation AntiVirus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation AntiVirus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Next Generation AntiVirus in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Next Generation AntiVirus company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next Generation AntiVirus revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Next Generation AntiVirus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Behavior and Event-Driven Major Player Table 3. AI-Driven Major Player Table 4. Others Major Player Table 5. Global Next Generation AntiVirus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Finance and Insurance Major Player Table 7. Manufacturing Major Player Table 8. Internet and High Technology Major Player Table 9. Others Major Player Table 10. Next Generation AntiVirus Industry Trends Table 11. Next Generation AntiVirus Industry Drivers Table 12. Next Generation AntiVirus Industry Opportunities and Challenges Table 13. Next Generation AntiVirus Industry Restraints Table 14. Global Next Generation AntiVirus Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Next Generation AntiVirus Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Next Generation AntiVirus Market Share by Region (2021-2026) Table 17. Global Next Generation AntiVirus Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Next Generation AntiVirus Market Share by Region (2027-2032) Table 19. Global Next Generation AntiVirus Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Next Generation AntiVirus Revenue Market Share by Players (2021-2026) Table 21. Global Next Generation AntiVirus Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Next Generation AntiVirus Key Players Headquarters & Area Served Table 23. Global Next Generation AntiVirus Players, Product Type & Application Table 24. Global Next Generation AntiVirus Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Next Generation AntiVirus by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Next Generation AntiVirus Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Next Generation AntiVirus Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Next Generation AntiVirus Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Next Generation AntiVirus Revenue Market Share by Type (2021-2026) Table 31. Global Next Generation AntiVirus Revenue Market Share by Type (2027-2032) Table 32. Global Next Generation AntiVirus Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Next Generation AntiVirus Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Next Generation AntiVirus Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Next Generation AntiVirus Revenue Market Share by Application (2021-2026) Table 36. Global Next Generation AntiVirus Revenue Market Share by Application (2027-2032) Table 37. Microsoft Company Information Table 38. Microsoft Business Overview Table 39. Microsoft Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Microsoft Next Generation AntiVirus Product Portfolio Table 41. Microsoft Recent Development Table 42. CrowdStrike Company Information Table 43. CrowdStrike Business Overview Table 44. CrowdStrike Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. CrowdStrike Next Generation AntiVirus Product Portfolio Table 46. CrowdStrike Recent Development Table 47. Trend Micro Company Information Table 48. Trend Micro Business Overview Table 49. Trend Micro Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Trend Micro Next Generation AntiVirus Product Portfolio Table 51. Trend Micro Recent Development Table 52. Trellix Company Information Table 53. Trellix Business Overview Table 54. Trellix Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Trellix Next Generation AntiVirus Product Portfolio Table 56. Trellix Recent Development Table 57. Palo Alto Networks Company Information Table 58. Palo Alto Networks Business Overview Table 59. Palo Alto Networks Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Palo Alto Networks Next Generation AntiVirus Product Portfolio Table 61. Palo Alto Networks Recent Development Table 62. Broadcom Company Information Table 63. Broadcom Business Overview Table 64. Broadcom Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Broadcom Next Generation AntiVirus Product Portfolio Table 66. Broadcom Recent Development Table 67. Sophos Company Information Table 68. Sophos Business Overview Table 69. Sophos Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Sophos Next Generation AntiVirus Product Portfolio Table 71. Sophos Recent Development Table 72. Bitdefender Company Information Table 73. Bitdefender Business Overview Table 74. Bitdefender Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Bitdefender Next Generation AntiVirus Product Portfolio Table 76. Bitdefender Recent Development Table 77. Cisco Company Information Table 78. Cisco Business Overview Table 79. Cisco Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Cisco Next Generation AntiVirus Product Portfolio Table 81. Cisco Recent Development Table 82. VMware Carbon Black Company Information Table 83. VMware Carbon Black Business Overview Table 84. VMware Carbon Black Next Generation AntiVirus Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. VMware Carbon Black Next Generation AntiVirus Product Portfolio Table 86. VMware Carbon Black Recent Development Table 87. Check Point Company Information Table 88. Check Point Business Overview Table 89. Check Point Next Generation AntiVirus Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Check Point Next Generation AntiVirus Product Portfolio Table 91. Check Point Recent Development Table 92. Malwarebytes Company Information Table 93. Malwarebytes Business Overview Table 94. Malwarebytes Next Generation AntiVirus Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Malwarebytes Next Generation AntiVirus Product Portfolio Table 96. Malwarebytes Recent Development Table 97. Fortinet Company Information Table 98. Fortinet Business Overview Table 99. Fortinet Next Generation AntiVirus Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Fortinet Next Generation AntiVirus Product Portfolio Table 101. Fortinet Recent Development Table 102. BlackBerry Cylance Company Information Table 103. BlackBerry Cylance Business Overview Table 104. BlackBerry Cylance Next Generation AntiVirus Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. BlackBerry Cylance Next Generation AntiVirus Product Portfolio Table 106. BlackBerry Cylance Recent Development Table 107. North America Next Generation AntiVirus Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Next Generation AntiVirus Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Next Generation AntiVirus Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Next Generation AntiVirus Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Next Generation AntiVirus Revenue by Country (2021-2026) & (US$ Million) Table 113. North America Next Generation AntiVirus Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe Next Generation AntiVirus Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Next Generation AntiVirus Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Next Generation AntiVirus Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Next Generation AntiVirus Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Next Generation AntiVirus Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe Next Generation AntiVirus Revenue by Country (US$ Million) & (2027-2032) Table 121. China Next Generation AntiVirus Revenue by Type (2021-2026) & (US$ Million) Table 122. China Next Generation AntiVirus Revenue by Type (2027-2032) & (US$ Million) Table 123. China Next Generation AntiVirus Revenue by Application (2021-2026) & (US$ Million) Table 124. China Next Generation AntiVirus Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Next Generation AntiVirus Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Next Generation AntiVirus Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Next Generation AntiVirus Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Next Generation AntiVirus Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Next Generation AntiVirus Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Next Generation AntiVirus Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia Next Generation AntiVirus Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA Next Generation AntiVirus Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA Next Generation AntiVirus Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA Next Generation AntiVirus Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA Next Generation AntiVirus Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA Next Generation AntiVirus Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA Next Generation AntiVirus Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Next Generation AntiVirus Image Figure 2. Global Next Generation AntiVirus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next Generation AntiVirus Market Size Share 2021 VS 2025 VS 2032 Figure 4. Behavior and Event-Driven Image Figure 5. AI-Driven Image Figure 6. Others Image Figure 7. Global Next Generation AntiVirus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Next Generation AntiVirus Market Size Share 2021 VS 2025 VS 2032 Figure 9. Finance and Insurance Image Figure 10. Manufacturing Image Figure 11. Internet and High Technology Image Figure 12. Others Image Figure 13. Global Next Generation AntiVirus Market Size (US$ Million) & (2021-2032) Figure 14. Global Next Generation AntiVirus Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Next Generation AntiVirus Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Next Generation AntiVirus Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Next Generation AntiVirus Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Next Generation AntiVirus Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Next Generation AntiVirus Revenue Market Share by Type (2021-2032) Figure 21. Global Next Generation AntiVirus Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Next Generation AntiVirus Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Next Generation AntiVirus Revenue Market Share by Application (2021-2032) Figure 24. North America Next Generation AntiVirus Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Next Generation AntiVirus Revenue Share by Type (2021-2032) Figure 26. North America Next Generation AntiVirus Revenue Share by Application (2021-2032) Figure 27. North America Next Generation AntiVirus Revenue Share by Country (2021-2032) Figure 28. United States Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Next Generation AntiVirus Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Next Generation AntiVirus Revenue Share by Type (2021-2032) Figure 33. Europe Next Generation AntiVirus Revenue Share by Application (2021-2032) Figure 34. Europe Next Generation AntiVirus Revenue Share by Country (2021-2032) Figure 35. Germany Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Next Generation AntiVirus Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Next Generation AntiVirus Revenue Share by Type (2021-2032) Figure 45. China Next Generation AntiVirus Revenue Share by Application (2021-2032) Figure 46. Asia Next Generation AntiVirus Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Next Generation AntiVirus Revenue Share by Type (2021-2032) Figure 48. Asia Next Generation AntiVirus Revenue Share by Application (2021-2032) Figure 49. Asia Next Generation AntiVirus Revenue Share by Region (2021-2032) Figure 50. Japan Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Next Generation AntiVirus Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Next Generation AntiVirus Revenue Share by Type (2021-2032) Figure 58. SAMEA Next Generation AntiVirus Revenue Share by Application (2021-2032) Figure 59. SAMEA Next Generation AntiVirus Revenue Share by Country (2021-2032) Figure 60. Brazil Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Next Generation AntiVirus Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Behavior and Event-Driven
  • AI-Driven
  • Others
Applications
  • Finance and Insurance
  • Manufacturing
  • Internet and High Technology
  • Others
Companies covered
  • Microsoft
  • CrowdStrike
  • Trend Micro
  • Trellix
  • Palo Alto Networks
  • Broadcom
  • Sophos
  • Bitdefender
  • Cisco
  • VMware Carbon Black
  • Check Point
  • Malwarebytes
  • Fortinet
  • BlackBerry Cylance

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Next Generation AntiVirus Market by Type
  3. 1.2.1 Global Next Generation AntiVirus Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Behavior and Event-Driven
  5. 1.2.3 AI-Driven
  6. 1.2.4 Others
  7. 1.3 Next Generation AntiVirus Market by Application
  8. 1.3.1 Global Next Generation AntiVirus Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Finance and Insurance
  10. 1.3.3 Manufacturing
  11. 1.3.4 Internet and High Technology
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Next Generation AntiVirus Market Dynamics
  1. 2.1 Next Generation AntiVirus Industry Trends
  2. 2.2 Next Generation AntiVirus Industry Drivers
  3. 2.3 Next Generation AntiVirus Industry Opportunities and Challenges
  4. 2.4 Next Generation AntiVirus Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Next Generation AntiVirus Market Perspective (2021-2032)
  2. 3.2 Global Next Generation AntiVirus Growth Trends by Region
  3. 3.2.1 Global Next Generation AntiVirus Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Next Generation AntiVirus Market Size by Region (2021-2026)
  5. 3.2.3 Global Next Generation AntiVirus Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Next Generation AntiVirus Revenue by Players
  2. 4.1.1 Global Next Generation AntiVirus Revenue by Players (2021-2026)
  3. 4.1.2 Global Next Generation AntiVirus Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Next Generation AntiVirus Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Next Generation AntiVirus Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Next Generation AntiVirus Key Players Headquarters & Area Served
  7. 4.4 Global Next Generation AntiVirus Players, Product Type & Application
  8. 4.5 Global Next Generation AntiVirus Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Next Generation AntiVirus Market CR5 and HHI
  11. 4.6.3 2025 Next Generation AntiVirus Tier 1, Tier 2, and Tier 3
5 Next Generation AntiVirus Market Size by Type
  1. 5.1 Global Next Generation AntiVirus Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Next Generation AntiVirus Revenue by Type (2021-2032)
  3. 5.3 Global Next Generation AntiVirus Revenue Market Share by Type (2021-2032)
6 Next Generation AntiVirus Market Size by Application
  1. 6.1 Global Next Generation AntiVirus Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Next Generation AntiVirus Revenue by Application (2021-2032)
  3. 6.3 Global Next Generation AntiVirus Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Microsoft
  2. 7.1.1 Microsoft Company Information
  3. 7.1.2 Microsoft Business Overview
  4. 7.1.3 Microsoft Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Microsoft Next Generation AntiVirus Product Portfolio
  6. 7.1.5 Microsoft Recent Developments
  7. 7.2 CrowdStrike
  8. 7.2.1 CrowdStrike Company Information
  9. 7.2.2 CrowdStrike Business Overview
  10. 7.2.3 CrowdStrike Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CrowdStrike Next Generation AntiVirus Product Portfolio
  12. 7.2.5 CrowdStrike Recent Developments
  13. 7.3 Trend Micro
  14. 7.3.1 Trend Micro Company Information
  15. 7.3.2 Trend Micro Business Overview
  16. 7.3.3 Trend Micro Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Trend Micro Next Generation AntiVirus Product Portfolio
  18. 7.3.5 Trend Micro Recent Developments
  19. 7.4 Trellix
  20. 7.4.1 Trellix Company Information
  21. 7.4.2 Trellix Business Overview
  22. 7.4.3 Trellix Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Trellix Next Generation AntiVirus Product Portfolio
  24. 7.4.5 Trellix Recent Developments
  25. 7.5 Palo Alto Networks
  26. 7.5.1 Palo Alto Networks Company Information
  27. 7.5.2 Palo Alto Networks Business Overview
  28. 7.5.3 Palo Alto Networks Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Palo Alto Networks Next Generation AntiVirus Product Portfolio
  30. 7.5.5 Palo Alto Networks Recent Developments
  31. 7.6 Broadcom
  32. 7.6.1 Broadcom Company Information
  33. 7.6.2 Broadcom Business Overview
  34. 7.6.3 Broadcom Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Broadcom Next Generation AntiVirus Product Portfolio
  36. 7.6.5 Broadcom Recent Developments
  37. 7.7 Sophos
  38. 7.7.1 Sophos Company Information
  39. 7.7.2 Sophos Business Overview
  40. 7.7.3 Sophos Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sophos Next Generation AntiVirus Product Portfolio
  42. 7.7.5 Sophos Recent Developments
  43. 7.8 Bitdefender
  44. 7.8.1 Bitdefender Company Information
  45. 7.8.2 Bitdefender Business Overview
  46. 7.8.3 Bitdefender Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bitdefender Next Generation AntiVirus Product Portfolio
  48. 7.8.5 Bitdefender Recent Developments
  49. 7.9 Cisco
  50. 7.9.1 Cisco Company Information
  51. 7.9.2 Cisco Business Overview
  52. 7.9.3 Cisco Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cisco Next Generation AntiVirus Product Portfolio
  54. 7.9.5 Cisco Recent Developments
  55. 7.10 VMware Carbon Black
  56. 7.10.1 VMware Carbon Black Company Information
  57. 7.10.2 VMware Carbon Black Business Overview
  58. 7.10.3 VMware Carbon Black Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  59. 7.10.4 VMware Carbon Black Next Generation AntiVirus Product Portfolio
  60. 7.10.5 VMware Carbon Black Recent Developments
  61. 7.11 Check Point
  62. 7.11.1 Check Point Company Information
  63. 7.11.2 Check Point Business Overview
  64. 7.11.3 Check Point Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Check Point Next Generation AntiVirus Product Portfolio
  66. 7.11.5 Check Point Recent Developments
  67. 7.12 Malwarebytes
  68. 7.12.1 Malwarebytes Company Information
  69. 7.12.2 Malwarebytes Business Overview
  70. 7.12.3 Malwarebytes Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Malwarebytes Next Generation AntiVirus Product Portfolio
  72. 7.12.5 Malwarebytes Recent Developments
  73. 7.13 Fortinet
  74. 7.13.1 Fortinet Company Information
  75. 7.13.2 Fortinet Business Overview
  76. 7.13.3 Fortinet Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Fortinet Next Generation AntiVirus Product Portfolio
  78. 7.13.5 Fortinet Recent Developments
  79. 7.14 BlackBerry Cylance
  80. 7.14.1 BlackBerry Cylance Company Information
  81. 7.14.2 BlackBerry Cylance Business Overview
  82. 7.14.3 BlackBerry Cylance Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BlackBerry Cylance Next Generation AntiVirus Product Portfolio
  84. 7.14.5 BlackBerry Cylance Recent Developments
8 North America
  1. 8.1 North America Next Generation AntiVirus Revenue (2021-2032)
  2. 8.2 North America Next Generation AntiVirus Revenue by Type (2021-2032)
  3. 8.2.1 North America Next Generation AntiVirus Revenue by Type (2021-2026)
  4. 8.2.2 North America Next Generation AntiVirus Revenue by Type (2027-2032)
  5. 8.3 North America Next Generation AntiVirus Revenue Share by Type (2021-2032)
  6. 8.4 North America Next Generation AntiVirus Revenue by Application (2021-2032)
  7. 8.4.1 North America Next Generation AntiVirus Revenue by Application (2021-2026)
  8. 8.4.2 North America Next Generation AntiVirus Revenue by Application (2027-2032)
  9. 8.5 North America Next Generation AntiVirus Revenue Share by Application (2021-2032)
  10. 8.6 North America Next Generation AntiVirus Revenue by Country
  11. 8.6.1 North America Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Next Generation AntiVirus Revenue by Country (2021-2026)
  13. 8.6.3 North America Next Generation AntiVirus Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Next Generation AntiVirus Revenue (2021-2032)
  2. 9.2 Europe Next Generation AntiVirus Revenue by Type (2021-2032)
  3. 9.2.1 Europe Next Generation AntiVirus Revenue by Type (2021-2026)
  4. 9.2.2 Europe Next Generation AntiVirus Revenue by Type (2027-2032)
  5. 9.3 Europe Next Generation AntiVirus Revenue Share by Type (2021-2032)
  6. 9.4 Europe Next Generation AntiVirus Revenue by Application (2021-2032)
  7. 9.4.1 Europe Next Generation AntiVirus Revenue by Application (2021-2026)
  8. 9.4.2 Europe Next Generation AntiVirus Revenue by Application (2027-2032)
  9. 9.5 Europe Next Generation AntiVirus Revenue Share by Application (2021-2032)
  10. 9.6 Europe Next Generation AntiVirus Revenue by Country
  11. 9.6.1 Europe Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Next Generation AntiVirus Revenue by Country (2021-2026)
  13. 9.6.3 Europe Next Generation AntiVirus Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Next Generation AntiVirus Revenue (2021-2032)
  2. 10.2 China Next Generation AntiVirus Revenue by Type (2021-2032)
  3. 10.2.1 China Next Generation AntiVirus Revenue by Type (2021-2026)
  4. 10.2.2 China Next Generation AntiVirus Revenue by Type (2027-2032)
  5. 10.3 China Next Generation AntiVirus Revenue Share by Type (2021-2032)
  6. 10.4 China Next Generation AntiVirus Revenue by Application (2021-2032)
  7. 10.4.1 China Next Generation AntiVirus Revenue by Application (2021-2026)
  8. 10.4.2 China Next Generation AntiVirus Revenue by Application (2027-2032)
  9. 10.5 China Next Generation AntiVirus Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Next Generation AntiVirus Revenue (2021-2032)
  2. 11.2 Asia Next Generation AntiVirus Revenue by Type (2021-2032)
  3. 11.2.1 Asia Next Generation AntiVirus Revenue by Type (2021-2026)
  4. 11.2.2 Asia Next Generation AntiVirus Revenue by Type (2027-2032)
  5. 11.3 Asia Next Generation AntiVirus Revenue Share by Type (2021-2032)
  6. 11.4 Asia Next Generation AntiVirus Revenue by Application (2021-2032)
  7. 11.4.1 Asia Next Generation AntiVirus Revenue by Application (2021-2026)
  8. 11.4.2 Asia Next Generation AntiVirus Revenue by Application (2027-2032)
  9. 11.5 Asia Next Generation AntiVirus Revenue Share by Application (2021-2032)
  10. 11.6 Asia Next Generation AntiVirus Revenue by Country
  11. 11.6.1 Asia Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Next Generation AntiVirus Revenue by Country (2021-2026)
  13. 11.6.3 Asia Next Generation AntiVirus Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Next Generation AntiVirus Revenue (2021-2032)
  2. 12.2 SAMEA Next Generation AntiVirus Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Next Generation AntiVirus Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Next Generation AntiVirus Revenue by Type (2027-2032)
  5. 12.3 SAMEA Next Generation AntiVirus Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Next Generation AntiVirus Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Next Generation AntiVirus Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Next Generation AntiVirus Revenue by Application (2027-2032)
  9. 12.5 SAMEA Next Generation AntiVirus Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Next Generation AntiVirus Revenue by Country
  11. 12.6.1 SAMEA Next Generation AntiVirus Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Next Generation AntiVirus Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Next Generation AntiVirus Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst